| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |